Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six- month trial

Fertility and Sterility

Volumn 70, Issue 1, 1998, Pages 107-110

  Casson, Peter R ^a   Santoro, Nanette ^b   Elkind Hirsch, Karen ^b   Carson, Sandra A ^b   Hornsby, Peter J ^b   Abraham, Guy ^b   Buster, John E ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Androgen replacement; DHEA; DHEAS; Menopause

Indexed keywords

APOLIPOPROTEIN A1; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; INSULIN; PRASTERONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY FAT; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; IMMUNE STATUS; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIVER FUNCTION TEST; MENOPAUSE; MORPHOMETRICS; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANDROGENS; BODY COMPOSITION; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIPOPROTEINS, HDL; MIDDLE AGED; POSTMENOPAUSE; TIME FACTORS;

EID: 0032124833     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00121-6     Document Type: Article

References (16)

1. 1. Casson PR, Buster JE. DHEA administration to humans: panacea or palaver? Semin Reprod Endocrinol 1995;13:247-56.
2. 2. Bates GW, Egerman RS, Umstot ES, Buster JE, Casson PR. Dehydroepiandrosterone attenuates study-induced declines in insulin sensitivity in postmenopausal women. In: Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE, editors. Dehydroepiandrosterone (DHEA) and aging [abstract]. New York: NY Acad Sci, 1995:9.
3. 3. Diamond P, Cusan L, Gomez JL, Belanger A, Labrie C. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 1996;150:S43-50.
4. 4. Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997;82:3498-505.
5. 5. Casson PR, Andersen RN, Herrod HG, Stentz FB, Straughn AB, Abraham GE, et al. Oral dehydroepiandrosterone (DHEA) in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 1993;169:1536-9.
6. 6. Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of dehydroepiandrosterone. J Clin Invest 1988;82:712-20.
7. 7. Flood JF, Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 1988;448:178-81.
8. 8. Schwartz AG, Pashko LL. Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs. J Cell Biochem 1993;17G:73-9.
9. 9. Buster JE, Casson PR, Straughn AB, Dale D, Umstot ES, Chiamori N, et al. Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary bioavailability and dose proportionality studies. Am J Obstet Gynecol 1992;166:1163-70.
10. 10. Casson PR, Faquin LC, Stentz FB, Straughn AB, Andersen RN, Abraham GE, et al. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 1995;63:1027-31.
11. 11. Bergman R, Beard J, Chen M. The minimal modeling method assessment of insulin sensitivity and B-cell function in vivo. In: Clarke W, Larner J, Pohl S, editors. Methods in diabetes research. New York: John Wiley and Sons, 1986:15-34.
12. 12. Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360-7.
13. 13. Casson PR, Straughn AB, Umstot ES. Delivery of dehydroepiandrosterone (DHEA) to premenopausal women: effects of micronization and non-oral administration. Am J Obstet Gynecol 1996;174:649-53.
14. 14. Yen SCC, Morales AJ, Khorram O. Replacement of DHEA in aging men and women: potential remedial effects. In: Bellino FL, Daynes RA, Hornsby PJ, Lavrin DH, Nestler JE, editors. Dehydroepiandrosterone (DHEA) and aging. New York: New York Academy of Science, 1995:128-42.
15. 15. Nass R, Huber RM, Klauss V, Muller OA, Schopohl J, Strasburger CJ. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab 1995;80: 552-7.
16. 16. Valcavi R, Gaddi O, Zini M, Iovicoli M, Mellino U, Portioli I. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 1995;80:659-66.